These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 33212336)

  • 21. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I; Srovnalova H; Kubikova R; Prasek J
    Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 23. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients.
    Hirata K; Hattori T; Kina S; Chen Q; Ohara M; Yokota T
    Mov Disord; 2020 Jun; 35(6):1037-1045. PubMed ID: 32163636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
    Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study.
    Wu K; O'Keeffe D; Politis M; O'Keeffe GC; Robbins TW; Bose SK; Brooks DJ; Piccini P; Barker RA
    Brain; 2012 Aug; 135(Pt 8):2449-57. PubMed ID: 22843413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopamine transporter abnormalities in patients with essential tremor.
    Isaias IU; Canesi M; Benti R; Gerundini P; Cilia R; Pezzoli G; Antonini A
    Nucl Med Commun; 2008 Apr; 29(4):349-53. PubMed ID: 18317299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.
    Voon V; Rizos A; Chakravartty R; Mulholland N; Robinson S; Howell NA; Harrison N; Vivian G; Ray Chaudhuri K
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):148-52. PubMed ID: 23899625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
    Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
    Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
    Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
    Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
    Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
    Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal dopamine transporter binding in patients with Parkinson's disease and severe occupational hydrocarbon exposure.
    Canesi M; Benti R; Marotta G; Cilia R; Isaias IU; Gerundini P; Pezzoli G; Antonini A
    Eur J Neurol; 2007 Mar; 14(3):297-9. PubMed ID: 17355550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Test-retest reproducibility of extrastriatal binding with
    Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
    Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome.
    Kessler KR; Hamscho N; Morales B; Menzel C; Barrero F; Vives F; Gispert S; Auburger G
    J Neural Transm (Vienna); 2005 Oct; 112(10):1345-53. PubMed ID: 15785866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
    Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
    Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
    Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.